Extended stop codon context predicts nonsense codon readthrough efficiency in human cells

Kotchaphorn Mangkalaphiban,Lianwu Fu,Ming Du,Kari Thrasher,Kim M. Keeling,David M. Bedwell,Allan Jacobson

DOI: https://doi.org/10.1038/s41467-024-46703-z

IF: 16.6

2024-03-20

Nature Communications

Abstract:Abstract Protein synthesis terminates when a stop codon enters the ribosome’s A-site. Although termination is efficient, stop codon readthrough can occur when a near-cognate tRNA outcompetes release factors during decoding. Seeking to understand readthrough regulation we used a machine learning approach to analyze readthrough efficiency data from published HEK293T ribosome profiling experiments and compared it to comparable yeast experiments. We obtained evidence for the conservation of identities of the stop codon, its context, and 3’-UTR length (when termination is compromised), but not the P-site codon, suggesting a P-site tRNA role in readthrough regulation. Models trained on data from cells treated with the readthrough-promoting drug, G418, accurately predicted readthrough of premature termination codons arising from CFTR nonsense alleles that cause cystic fibrosis. This predictive ability has the potential to aid development of nonsense suppression therapies by predicting a patient’s likelihood of improvement in response to drugs given their nonsense mutation sequence context.

multidisciplinary sciences

What problem does this paper attempt to address?

### Problems the Paper Aims to Solve This paper aims to investigate the regulatory mechanisms of stop codon readthrough in human cells and to predict the readthrough efficiency of specific stop codons using machine learning methods. Specifically: 1. **Understanding Readthrough Regulatory Mechanisms**: - Researchers analyzed ribosome profiling data from HEK293T cells to explore the impact of stop codons and their surrounding sequences on readthrough efficiency. These results were compared with similar experiments in yeast cells. 2. **Developing Machine Learning Models**: - Machine learning methods were used to train models to predict the readthrough efficiency of different stop codons under specific conditions. Notably, in cells treated with the readthrough-promoting drug G418, the model could accurately predict the readthrough efficiency of CFTR nonsense mutations (premature termination codons, PTCs) that cause cystic fibrosis. 3. **Application Prospects**: - This predictive capability is expected to be used in the development of nonsense suppression therapies, by predicting the response of patients' nonsense mutation sequences to drugs. In summary, this paper aims to provide new insights and tools for the treatment of diseases caused by nonsense mutations by deeply understanding the regulatory mechanisms of stop codon readthrough and developing corresponding predictive models.

Extended stop codon context predicts nonsense codon readthrough efficiency in human cells

Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3

Translation termination codons in protein synthesis and disease

Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression

mRNA-specific readthrough of nonsense codons by antisense oligonucleotides (R-ASOs)

Transcriptome-wide investigation of stop codon readthrough in Saccharomyces cerevisiae

A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion

Defining the high-translational readthrough stop codon context

Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development

Readthrough-induced misincorporated amino acid ratios guide mutant-specific therapeutic approaches for two CFTR nonsense mutations

Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules

Systematic analysis of nonsense variants uncovers peptide release rate as a novel modifier of nonsense-mediated mRNA decay efficiency

Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations

Premature Termination Codon Readthrough In Drosophila Varies In A Developmental And Tissue-Specific Manner

Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons

Translational readthrough potential of natural termination codons in eucaryotes – The impact of RNA sequence

Cysteine tRNA acts as a stop codon readthrough-inducing tRNA in the human HEK293T cell line

Mechanism-based approach in designing patient-specific combination therapies for nonsense mutation diseases

Recognition of 3′ nucleotide context and stop codon readthrough are determined during mRNA translation elongation

Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches

Rationalization and prediction of selective decoding of pseudouridine-modified nonsense and sense codons